Results 251 to 260 of about 67,015 (304)

Anterior mitral valve leaflet length and response to mavacamten in obstructive hypertrophic cardiomyopathy. [PDF]

open access: yesEur Heart J Imaging Methods Pract
Saleh D   +11 more
europepmc   +1 more source

Hypertrophic obstructive cardiomyopathy.

open access: yesTexas Heart Institute journal, 1995
T C, Mathew, E K, Ramsaran, D H, Spodick
openaire   +1 more source

Clinical burden of obstructive hypertrophic cardiomyopathy in France. [PDF]

open access: yesFront Cardiovasc Med
Charron P   +6 more
europepmc   +1 more source

SAFETY AND OUTCOMES OF CONCOMITANT AFICAMTEN AND DISOPYRAMIDE USE AND WITHDRAWAL IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: AN ANALYSIS OF REDWOOD-HCM COHORT 3, SEQUOIA-HCM, AND FOREST-HCM TRIALS

open access: hybrid
Ahmad Masri   +22 more
openalex   +1 more source

PERCUTANEOUS MITRAL PLICATION FOR WEANING BY VA–ECMO IN PATIENT WITH OBSTRUCTIVE SAM ASSOCIATED WITH PRECLINICAL PHENOTYPE OF HYPERTROPHIC CARDIOMYOPATHY AND STEMI COMPLICATED BY CARDIOGENIC SHOCK [PDF]

open access: bronze
Greta Rende   +11 more
openalex   +1 more source

Post-carvedilol myocardial function in cats with obstructive hypertrophic cardiomyopathy. [PDF]

open access: yesFront Vet Sci
Saito T   +6 more
europepmc   +1 more source

Effects of Mavacamten on Cardiac Magnetic Resonance Features in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy. [PDF]

open access: yesJACC Asia
Tian Z   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy